FDA Expects Greater Scientific Impact With Larger Advisory Board
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach is attempting to increase the impact of the agency's Science Board Advisory Committee by doubling the number of members and meetings